AlertWatch About Us | Founded by Dr. Kevin Tremper | AlertWatch, Inc.

About AlertWatch, Inc.

AlertWatch, Inc. is an Ann Arbor-based firm that develops and markets clinical decision support systems for hospitals. Founded in 2011, AlertWatch simplifies patient monitoring with intuitive products for the operating room and labor & delivery unit.

The Press Room

Take a look at some of our recent press coverage and press releases:

February, 2014: U-M Startup AlertWatch Gains FDA Clearance to Sell Patient Monitoring Software
August, 2013: AlertWatch Granted Second Patent and related press coverage
July, 2013: AlertWatch Lands Additional Investment
April, 2013: AlertWatch Raises $1 Million
April, 2013: AlertWatch Offers New Way to Monitor OR Patients
November, 2012: U-M Startups Amaze on Tech Tour

Meet the AlertWatch Team

Justin Adams
Chief Executive Officer

Kevin Tremper, PhD, MD
Founder & President

Jan Gombert
Quality System Manager

Jim Bagian, MD
Co-founder

Tyler Tremper
CTO

Bill Sheldon
Senior Developer

Joseph Connolly
Senior Developer

Jenny J. Mace
Administration & Research

The AlertWatch Board

Justin Adams
AlertWatch CEO

Kevin Tremper, PhD, MD
Founder & President

Tony Mira
President & CEO,
Anesthesia Business Consultants

Dave Morin
Healthcare Technology Entrepreneur

AlertWatch Advisors

Mary Campbell
Managing Director, EDF Ventures

steve-haakenson

Steve Haakenson
Executive Director,
Biosciences Research &
Commercialization Center

AlertWatch Partners

Learn more about our partner organizations.

Copyright 2019 AlertWatch. All rights reserved.

AlertWatch:OR and AlertWatch:OB are FDA 510(k)-cleared for sale in the United States, and are intended for use by clinicians for secondary monitoring of patients . AlertWatch accomplishes this by aggregating data from a multitude of sources and displaying them at a central location. Once alerted, the clinician must refer to the primary monitoring device before making a clinical decision.

AlertWatch:ICU, AlertWatch:AC, and AlertWatch:PACU are pending FDA clearance and are currently only available for IRB-sponsored research. Some images and interfaces are enhanced for clarity.